Moberg Pharma AB | Income Statement

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
157,389.00
200,180.00
285,566.00
334,304.00
439,032.00
439,041
Cost of Goods Sold (COGS) incl. D&A
46,072.00
57,132.00
83,136.00
117,089.00
163,546.00
141,361
Gross Income
111,317.00
143,048.00
202,430.00
217,215.00
275,486.00
297,680
SG&A Expense
126,440.00
131,613.00
170,851.00
197,831.00
237,230.00
248,368
EBIT
15,123.00
11,435.00
32,386.00
21,465.00
38,255.00
49,312
Unusual Expense
-
-
-
-
3,243.00
6,459
Non Operating Income/Expense
886.00
6,511.00
2,798.00
45,343.00
9,577.00
9,048
Interest Expense
2,483.00
1,555.00
654.00
21,255.00
39,402.00
38,974
Pretax Income
16,175.00
16,577.00
34,567.00
46,545.00
11,673.00
25,846
Income Tax
4,817.00
4,309.00
9,030.00
13,877.00
515.00
6,008
Consolidated Net Income
11,358.00
12,268.00
25,537.00
32,668.00
11,158.00
19,838
Net Income
11,358.00
12,268.00
25,537.00
32,668.00
11,158.00
19,838
Net Income After Extraordinaries
11,358.00
12,268.00
25,537.00
32,668.00
11,158.00
19,838
Net Income Available to Common
11,358.00
12,268.00
25,537.00
32,668.00
11,158.00
19,838
EPS (Basic)
1.01
0.96
1.80
2.27
0.64
1.14
Basic Shares Outstanding
11,265.70
12,719.60
14,172.10
14,413.60
17,428.70
17,440.80
EPS (Diluted)
0.97
0.95
1.78
2.25
0.64
1.14
Diluted Shares Outstanding
11,735.80
12,859.50
14,386.60
14,503.70
17,540.30
17,462.40
EBITDA
9,018.00
19,503.00
43,602.00
37,199.00
76,622.00
86,237
Other Operating Expense
-
-
807.00
2,081.00
1.00
-
Non-Operating Interest Income
545.00
186.00
37.00
992.00
-
1

About Moberg Pharma AB

View Profile
Address
Gustavslundsvägen 42, 5 tr
Bromma AB 167 51
Sweden
Employees -
Website http://www.mobergpharma.se
Updated 07/08/2019
Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. It offers its products through the following brands: Kerasal, Kerasal Nail, Balmex, NewSkin, Dermoplast, Domeboro, and Fiber Choice. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden.